106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2020 All rights reserved
ASCOFEM10203
Disclaimer
is pocket guide is derived om recommendations in the American Society of Clinical Oncology
Guideline. is resource is a practice tool based on ASCO
®
practice guidelines and is not intended
to substitute for the independent professional judgment of the treating physician. Practice guidelines
do not account for individual variation among patients. is pocket guide does not purport to
suggest any particular course of medical treatment. Use of the practice guidelines and this resource
are voluntary. e practice guidelines and additional information are available at http://asco.org/
supportive-care-guidelines. Copyright © 2020 by American Society of Clinical Oncology. All rights
reserved.
Abbreviations
ASCO, American Society of Clinical Oncolog y; ASTRO, American Society for Radiation
Oncolog y; BMA, bone modifying agents; CPGC, clinical practice guideline committee;
MRI, magnetic resonance imaging ; MSTS, Musculoskeletal Tumor Society
Source
Musculoskeletal Tumor Society (MSTS), American Society for Radiation Oncolog y
(ASTRO), and American Society of Clinical Oncolog y (ASCO). e Treatment of Metastatic
Carcinoma and Myeloma of the Femur: Clinical Practice Guideline; 2020. Available at: msts.
org/view/download.php/education/mbd-cpg-amended. Accessed: September 29, 2020.
ASCO believes that cancer clinical trials are vital to inform medical decisions and
improve cancer care and that all patients should have the opportunity to participate.
Additional information, which may include data supplements, slide sets, and other clinical
tools and resources, is available at http://asco.org/supportive-care-guidelines.
